Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabineShigehiro Tsukahara, Dongchon Kang|Scientific Reports|2022Cited by 4
Cancer Genomic Profiling Identified Dihydropyrimidine Dehydrogenase Deficiency in Bladder Cancer Promotes Vulnerability to GemcitabineShigehiro Tsukahara, Dongchon Kang|Research Square|2022Cited by 0
膀胱癌におけるジヒドロピリミジン脱水素酵素の欠損がゲムシタビンに対する感受性を促進するShigehiro Tsukahara|Institutional Repositories DataBase (IRDB)|2022Cited by 0